Alcon AG | ALC - Operating Expenses


Alcon AG reported $2.41B in Operating Expenses for its fiscal quarter ending in March of 2026.





Operating Expenses Change Date
AstraZeneca USD 8.18B 4.35B Mar/2026
Bayer EUR 9.88B 452M Mar/2026
Essilor EUR 13.09B 1.07B Dec/2025
Fresenius EUR 5.25B 337M Dec/2025
Fresenius Medical Care EUR 4.34B 63M Mar/2026
GlaxoSmithKline GBP 5.34B 1.85B Mar/2026
GRIFOLS EUR 1.45B 255.28M Mar/2026
Lonza CHF 2.9B 184M Jun/2025
Merck EUR 4.09B 687M Mar/2026
Novartis USD 9.29B 507M Mar/2026
Philips EUR 3.6B 775M Mar/2026
Roche Holding CHF 21.01B 10.84B Dec/2025
Sanofi EUR 9.31B 1.2B Mar/2026
Smith & Nephew USD 2.52B 84M Dec/2025
Sonova Holding CHF 1.52B 59.9M Dec/2025
UCB EUR 2.96B 196M Dec/2025